IPSPi

IPSPi is an Indian multinational pharmaceutical company that specializes in the development and manufacture of pharmaceutical products in the therapeutic areas of dermatology, gastroenterology, respiratory, and cardiovascular.

The company was founded in 1982 by a group of entrepreneurs with a vision to become a leading pharmaceutical company in the country. Over the years, IPSPi has expanded its operations globally, establishing business relationships with numerous countries including the United States, the United Kingdom, and the European Union.

IPSPi's product portfolio includes a range of prescription and over-the-counter (OTC) medications that cater to various health conditions. The company has developed a reputation for its innovative approach to drug development, which has led to the creation of several blockbuster products. IPSPi's research and development capabilities have enabled it to stay at the forefront of the Indian pharmaceutical industry.

IPSPi has a robust manufacturing and quality control system in place that ensures the production of high-quality drugs that meet international standards. The company has obtained approval from various regulatory authorities including the US FDA, the UK MHRA, and the EU EMA, among others.

IPSPi has a significant presence in the Indian healthcare market, with a strong distribution network that covers over 90 countries worldwide. The company has a diverse workforce of thousands of employees across various functions. IPSPi's commitment to innovation, quality, and customer satisfaction has enabled it to establish a presence in the global pharmaceutical landscape.